ArticlePediatric research2026
Low prevalence of celiac disease in French children, a nationwide study.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere are differences in prevalence and incidence across Europe without updated data for France. The aim of this study was to fill this gap obtaining epidemiological data of French children with celiac disease (CD).
methodsWe used the French Health Data System (SNDS) to identify <18-year-old patients with CD between 2011 and 22. CD identification: 1/hospitalization stay for CD, or 2/ status of CD as long-term disease, or 3/serological diagnosis (two tests for transglutaminase antibodies (TGA) within 13 months and one endomysium antibodies (EMA) test within seven months after a TGA test).
results41690 children with CD were identified over 2011-2022. The male-to-female sex ratio was 0.88. In 2022, the national prevalence was 0.15% among children, ranging from 0.08% in the North-West to 0.25% in the South-East of France. The incidence rate ranged from 12.4 in 2020 to 17.4 per 100000 children in 2012, with a median age increasing from six in 2011 to seven in 2015. Comorbidities included thyroid disease (1.7%), and type 1 diabetes (9.7%).
conclusionsThe prevalence of pediatric CD is low in France, with differences across regions. However, the age at diagnosis and the female predominance are in agreement with recent studies. IMPACT: This nationwide study revealed a lower prevalence of CD in French children than in other European countries, with regional variations. The study confirmed the female predominance and the age of seven at diagnosis. These data should be useful to give screening advices, looking for CD even in older children with atypical signs.
Identifiers
42918825What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.